Gossamer Bio
GOSS
GOSS
182 hedge funds and large institutions have $56.3M invested in Gossamer Bio in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 71 increasing their positions, 49 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 53
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
90% less capital invested
Capital invested by funds: $585M → $56.3M (-$529M)
Holders
182
Holding in Top 10
1
Calls
$1.24M
Puts
$189K
Top Buyers
| 1 | +$16.1M | |
| 2 | +$14.2M | |
| 3 | +$6.92M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$6.88M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$5.03M |
Top Sellers
| 1 | -$26.9M | |
| 2 | -$13.9M | |
| 3 | -$9.73M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$9.69M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$8.43M |
